Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (3): 278-282.doi: 10.3736/jcim20080312

• Original Experimental Research • Previous Articles     Next Articles

Effects of ginsenoside and berberine on secretion of immunosuppressive cytokines in lung carcinoma cell line PG

Yu Hao(), Ping Wang, Jun Wu, Quan-ying Qiu   

  1. Department of Pathogenic Organism and Immunology, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
  • Received:2007-07-25 Online:2008-03-20 Published:2008-03-15
  • Contact: Y Hao

Objective: To observe the effects of ginsenoside (Gs) and berberine (Ber), two kinds of active components of traditional Chinese herbal medicine, on transforming growth factor-beta1 (TGF-β1) and prostaglandin E2 (PGE2) in PG cells.Methods: Co-culture system of human lung carcinoma cell line PG and human T lymphocyte cell line Jurkat was established. PG cells were treated with Gs (100 μg/ml) and Ber (10 μg/ml) for twenty-four hours, and then cocultured with Jurkat cells. After 24-hour coculture, the state of Jurkat cells was observed with inverted microscope. The viable count of Jurkat cells was detected by trypan blue staining after 6- and 24-hour coculture, and the apoptosis of Jurkat cells was evaluated by flow cytometry. PG cells were treated with 100, 50, 25 μg/ml Gs and 10, 5, 2.5 μg/ml Ber respectively, and the content of TGF-β1 and PGE2 in PG cells was detected by enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA) method.Results: After coculture with PG cells treated with Gs and Ber, the number of Jurkat cells was less than blank control group, and the apoptosis rates of Jurkat cells in Gs- and Ber-treated groups were higher than blank control group. Gs and Ber could promote the secretion of TGF-β1 in PG cells, but could not change the level of PGE2.Conclusion: Gs and Ber can promote the growth inhibition and apoptosis of Jurkat cells induced by PG cells, which may be related to the up-regulation of Gs and Ber on TGF-β1 secretion in PG cells.

Key words: ginsenosides, berberine, suppressor factors, immunologic, transforming growth factor (31, prostaglandins E

CLC Number: 

  • R734.2

Figure 1

Growth status of Jurkat cells cocultured with PG cells treated with Gs and Ber for 24 h (Inverted microscope, ×100) A: Jurkat cells group (uncocultured control); B: Blank control group (cocultured with untreated PG cells); C: Gs-treated group (cocultured with Gs-treated PG cells); D: Ber-treated group (cocultured with Ber-treated PG cells)."

Table 1

Viable cell count of Jurkat cells after coculture with PG cells ($\bar{x}$±s,105/ml)"

Group n Viable cell count of Jurkat cells
After 6 h coculture After 24 h coculture
Jurkat cells 3 3.0±0.2 5.4±0.3
Blank control 3 2.4±0.2 3.6±0.2
Gs-treated 3 1.4±0.1**△△ 2.2±0.2**△△
Ber-treated 3 2.4±0.1 2.7±0.2**△△

Table 2

Apoptosis rate of Jurkat cells detected by flow cytometry ($\bar{x}$±s, %)"

Group n Early phase (Annexin-V-FITC) Middle-terminal phase ( PI ) Total apoptosis rate
Jurkat cells 3 5.57±1.20 4.67±0.57 10.24±1.49
Blank control 3 11.40±1.94△△ 36.69±2.29△△ 48.10±0.51△△
Gs-treated 3 15.79±0.54*△△ 40.40±1.81△△ 56.19±1.28**△△
Ber-treated 3 12.05±3.28△△ 40.03±3.26△△ 52.08±2.17*△△

Table 3

Content of TGF-β1 and PGE2 in PG cell culture supernatants ($\bar{x}$±s, ng/L)"

Group n TGF-β1 PGE2
Blank control 4 14.9±4.2 28.7±2.3
Gs1 (100 μg/ml)-treated 4 24.9±2.0* 28.9±11.3
Gs2 (50 μg/ml)-treated 4 16.0±3.5 18.2±6.8
Gs3 (25 μg/ml)-treated 4 20.4±2.4 19.1±8.5
Ber1 (10 μg/ml)-treated 4 21.0±1.2 28.9±6.1
Ber2 (5 μg/ml)-treated 4 30.4±4.4* 19.1±7.8
Ber3 (2.5 μg/ml)-treated 4 28.8±4.2* 24.3±1.1

Figure 2

Concentration of TGF-β1 in PG cells"

Figure 3

PG cell number detected by MTT method"

[1] Frumento G, Piazza T, Di Carlo E , et al. Targeting tumor-related immunosuppression for cancer immunotherapy[J]. Endocr Metab Immune Disord Drug Targets, 2006,6(3):233-237
doi: 10.2174/187153006778250019 pmid: 17017974
[2] Fukuchi M, Nakajima M, Miyazaki T , et al. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma[J]. J Surg Oncol, 2006,94(1):51-56
doi: 10.1002/(ISSN)1096-9098
[3] Schneider T, Sailer M, Ansorge S , et al. Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma[J]. J Neurooncol, 2006,79(1):61-65
doi: 10.1007/s11060-005-9116-7
[4] Mouri H, Sakaguchi K, Sawayama T , et al. Suppressive effects of transforming growth factor-beta1 produced by hepatocellular carcinoma cell lines on interferon-gamma production by peripheral blood mononuclear cells[J]. Acta Med Okayama, 2002,56(6):309-315
[5] Ashley DM, Kong FM, Bigner DD , et al. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model[J]. Cancer Res, 1998,59(2):302-309
[6] Harizi H, Norbert G . Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells[J]. Cell Immunol, 2004,228(2):99-109
doi: 10.1016/j.cellimm.2004.04.003
[7] Sherratt PJ , McLellan LI, Hayes JD.Positive and negative regulation of prostaglandin E2 biosynjournal in human colorectal carcinoma cells by cancer chemopreventive agents[J]. Biochem Pharmacol, 2003,66(1):51-61
doi: 10.1016/S0006-2952(03)00206-5
[8] Half E, Tang XM, Gwyn K , et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ[J]. Cancer Res, 2002,62(6):1676-1681
[9] Tatsuka M, Maeda M, Ota T . Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh2[J]. Jpn J Cancer Res, 2001,92(11):1184-1189
doi: 10.1111/cas.2001.92.issue-11
[10] Hao Y, Qiu QY, Wu J , et al. Effect of berberine on lymphocyte-endothelium adhesion and adhesion molecules expression[J]. Zhongguo Mian Yi Xue Za Zhi, 1999,15(11):523-525
郝钰, 邱全瑛, 吴珺 , 等. 小檗碱对淋巴细胞与血管内皮细胞粘附及粘附分子的影响[J]. 中国免疫学杂志, 1999,15(11):523-525
[11] Hao Y, Qiu QY, Fang SP . Flow cytometry analysis of the inhibition of berberine on lymphocyte proliferation[J]. Zhongguo Bing Li Sheng Li Za Zhi, 2000,16(10):1129
郝钰, 邱全瑛, 方素萍 . 小檗碱抑制淋巴细胞增殖的流式细胞分析[J]. 中国病理生理杂志, 2000,16(10):1129
[1] Noriko Shinjyo, James Parkinson, Jimmy Bell, Tatsuro Katsuno, Annie Bligh. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. Journal of Integrative Medicine, 2020, 18(2): 125-151.
[2] Khanh Nguyen, Jean Sparks, Felix O. Omoruyi. Investigation of the cytotoxicity, antioxidative and immune-modulatory effects of Ligusticum porteri (Osha) root extract on human peripheral blood lymphocytes. Journal of Integrative Medicine, 2016, 14(6): 465-472.
[3] Veena Sharma, Ritu Paliwal, Pracheta Janmeda, Shatruhan Sharma. Renoprotective effects of Moringa oleifera pods in 7,12-dimethylbenz[a]anthracene-exposed mice. Journal of Chinese Integrative Medicine, 2012, 10(10): 1171-1178.
[4] Sunil Kumar, Priyanka Gupta, Shalini Sharma, Dinesh Kumar. A review on immunostimulatory plants. Journal of Chinese Integrative Medicine, 2011, 9(2): 117-128.
[5] Shao-hua SONG, Xiao-yun SHEN, Guo-shan DING, Fang LIU, Zhen-meng WANG, Zhi-ren FU. Effects of astilbin on maturation and immunologic function of mouse bone marrow-derived dendritic cells. Journal of Chinese Integrative Medicine, 2010, 8(2): 145-151.
[6] L Liu, XQ Yue, LN Wang, W Gu, HL Xin, GY Zheng, CQ Ling. Preventive effects of a sachet of Chinese herbs on influenza and its immune regulation. Journal of Chinese Integrative Medicine, 2010, 8(10): 949-954.
[7] WEI Peng, JIAO Lei, QIN Lu-ping, YAN Fei, HAN Ting, ZHANG Qiao-yan. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells. Journal of Chinese Integrative Medicine, 2009, 7(4): 342-348.
[8] Shreeraj H. Shah, Jayvadan K. Patel, Nirav V. Patel. Gastroretentive floating drug delivery systems with potential herbal drugs for Helicobacter pylori eradication: A review. Journal of Chinese Integrative Medicine, 2009, 7(10): 976-982.
[9] Wei Zhang, Liang-duo Jiang, Xiao-mei Zhang, Jian-jun Wu, Yuan Deng, Xiang-feng Lu. Influence of Feixian Formula on serum transforming growth factor-β1 and platelet-derived growth factor in rats with bleomycin-induced pulmonary fibrosis. Journal of Chinese Integrative Medicine, 2008, 6(6): 595-599.
[10] Jia-qing Zhang. Progress of diabetes research in traditional Chinese medicine in recent years. Journal of Chinese Integrative Medicine, 2007, 5(4): 373-377.
[11] Min Li​, Chang-quan Ling​, Xue-qiang Huang​, Zhi-lei Shen. Effects of ginsenosides extracted from ginseng stem and leaves on glucocorticoid receptor in different viscera in heat-damaged rats. Journal of Chinese Integrative Medicine, 2006, 4(2): 156-159.
[12] Dai-wei Cheng​, Yong Zou​, Ning Qian​, Chao-liang Wang​, Ying-biao Tian​, Da-li Wang​, Gui-xiang Zhao​, Zhen-yu Gao​. Effects of compound preparation of Cordyceps sinensis and Tripterygium hypoglaucum on survival time of pigskin after allogeneic transplantation. Journal of Chinese Integrative Medicine, 2006, 4(2): 185-188.
[13] Ying-lu Feng, Chang-quan Ling, De-zeng Zhu, Chao-qin Yu, Zhe Chen, Bai Li. Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: A randomized, controlled and double-blinded prospective trial. Journal of Chinese Integrative Medicine, 2005, 3(2): 99-102.
[14] Dai-jia Zhang, Zhi-long Xiu, Xin-hua Lin, Dong-jian Qi. Effects of three different drying methods on extraction and separation of ginsenosides from fresh ginseng. Journal of Chinese Integrative Medicine, 2004, 2(4): 292-294.
[15] Yu-ying Ma, Xin-min Zhang. Application of DNA microarray technology in immunological research and its inspiration to researches on traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2004, 2(2): 90-93.
Full text



[1] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[2] Ya-bing Zhou, Jian-er Yu, Jie Wu, Li Bai, Li-li Huo, Xin-guang Zhang, Li-qing Li . Effects of Chinese herbal medicine Bushen Gubiao Recipe on toll-like receptor 4 and CD4 +CD25 +foxp3 +regulatory T cells in mice with recurrent respiratory tract infections. Journal of Chinese Integrative Medicine, 2010, 8(11): 1053-1059
[3] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[4] Ji Chen, Qin Pan, Li-shuang Ye, Jia-ling Huang. English translation of cultural aspects of the titles of traditional Chinese medicine classics based on the skopos theory. Journal of Chinese Integrative Medicine, 2012, 10(11): 1316-1320
[5] Kishan Lal Tiwari, Shailesh Kumar Jadhav, Veenu Joshi. An updated review on medicinal herb genus Spilanthes. Journal of Chinese Integrative Medicine, 2011, 9(11): 1170-1178
[6] Zhao-guo Li. Studies on English translation of the titles of traditional Chinese medicine specialties. Journal of Chinese Integrative Medicine, 2010, 8(12): 1199-1206
[7] Mei-jun Lü, Hui-yong Zhang, Zhe Zhang, Guan-lin Yang. Measurement of health-related quality of life in coronary heart disease: A review. Journal of Chinese Integrative Medicine, 2011, 9(12): 1277-1285
[8] Yong-hong Li, Zong-wen Huang, Ping Xue, Jia Guo, Fu-qian He, Zheng You, Zheng-rong Wang. Effects of Chaiqin Chengqi Decoction on activation of nuclear factor-κB in pancreas of rats with acute necrotizing pancreatitis. Journal of Chinese Integrative Medicine, 2008, 6(2): 180-184
[9] Hong-li Xue, Wen-jian Wang, Jian-qiu Chen. Effects of Shenmai Huoxue Decoction on early diabetic peripheral neuropathy in rats. Journal of Chinese Integrative Medicine, 2005, 3(1): 31-34
[10] Lei Luo. Ways to translate linkage formation and zeugma in English for traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2005, 3(1): 83-84